Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial

DSpace Repository

Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial

Author: Erber, Ramona; Gluz, Oleg; Brunner, Nils; Kreipe, Hans Heinrich; Pelz, Enrico; Kates, Ronald; Bartels, Annette; Huober, Jens; Mohrmann, Svjetlana; Moustafa, Zehra; Liedtke, Cornelia; Moebus, Volker; Augustin, Doris; Thomssen, Christoph; Jaenicke, Fritz; Kiechle, Marion; Kuhn, Walther; Nitz, Ulrike; Harbeck, Nadia; Hartmann, Arndt
Tübinger Autor(en):
Huober, Jens
Published in: Breast Cancer Research and Treatment (2015), Bd. 150, H. 2, S. 279-288
Verlagsangabe: Springer
Language: English
Full text: http://dx.doi.org/10.1007/s10549-015-3310-x
ISSN: 0167-6806
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)